| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PLCIU | PELICAN ACQUISITION II CORP | N/A | $10.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| QMLS | QUMULUSAI INC | N/A | $7.32 | $24.50 | 234.70% | Strong Buy | 1 | N/A | N/A | N/A | N/A | |||
| AZUL | AZUL SA | N/A | $8.20 | $20.00 | 143.90% | Buy | 1 | N/A | N/A | N/A | N/A | |||
| OHAC | OCEANHAWK ACQUISITION CORP | N/A | $9.95 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| AIBZ | BITZERO HOLDINGS INC | N/A | $6.75 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| WLCO | WILCO 63 CORP | N/A | $9.78 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| NCO | SOUTHERN CROSS ACQUISITION I CORP | N/A | $9.85 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| REF | REFORMATION INC | N/A | $15.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| FJDIU | ARC GROUP SECURITIES ACQUISITION I | N/A | $9.96 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| CCCT | COLUMBUS CIRCLE CAPITAL CORP III | N/A | $9.84 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| PBAM | PRIVATE BANCORP OF AMERICA INC | N/A | $86.60 | N/A | N/A | N/A | N/A | 20.08% | 19.86% | 19.07% | 1.99% | |||
| CUVL | CLINUVEL PHARMACEUTICALS LTD | N/A | $6.90 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| AESP | AEON ACQUISITION I CORP | N/A | $9.94 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SCTX | SCRIBE THERAPEUTICS INC | N/A | $20.73 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| SKHY | SK HYNIX INC | N/A | $166.33 | $245.50 | 47.60% | Strong Buy | 9 | N/A | N/A | N/A | N/A | |||
| BREZ | BREEZE ACQUISITION CORP II | N/A | $9.96 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| BLSM | BLOSSOMHILL THERAPEUTICS INC | N/A | $16.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |